NeoGenomics Reports 17% Revenue Growth to Record $69 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Neogenomics (NEO) PT Raised to $22 at Craig-Hallum
October 30, 2018 4:00 PM EDTCraig-Hallum analyst Kevin Ellich raised the price target on Neogenomics (NASDAQ: NEO) to $22.00 while maintaining a Buy rating.
Ellich cited "excellent" Q3 results while the Genoptix deal ads another layer of growth.
... MoreNeogenomics (NEO) FV Raised to $20 at Janney Montgomery Scott
October 30, 2018 12:56 PM EDTJanney Montgomery Scott analyst Paul Knight raised his fair value target on Neogenomics (NASDAQ: NEO) to $20.00 while maintaining a Buy rating following Q3 results.
... More